Published in J Neurophysiol on May 01, 2001
Molecular mechanisms of resistance and toxicity associated with platinating agents. Cancer Treat Rev (2006) 5.08
Chemotherapy-induced peripheral neurotoxicity. Nat Rev Neurol (2010) 1.71
Oxaliplatin-induced cold hypersensitivity is due to remodelling of ion channel expression in nociceptors. EMBO Mol Med (2011) 1.50
The challenges of colorectal cancer survivorship. J Natl Compr Canc Netw (2009) 1.44
Mice with cisplatin and oxaliplatin-induced painful neuropathy develop distinct early responses to thermal stimuli. Mol Pain (2009) 1.37
Anticancer drug oxaliplatin induces acute cooling-aggravated neuropathy via sodium channel subtype Na(V)1.6-resurgent and persistent current. Proc Natl Acad Sci U S A (2012) 1.26
Oxaliplatin induces hyperexcitability at motor and autonomic neuromuscular junctions through effects on voltage-gated sodium channels. Br J Pharmacol (2005) 1.19
Survey of oxaliplatin-associated neurotoxicity using an interview-based questionnaire in patients with metastatic colorectal cancer. BMC Cancer (2005) 1.16
Characterization of oxaliplatin-induced chronic painful peripheral neuropathy in the rat and comparison with the neuropathy induced by paclitaxel. Neuroscience (2011) 1.16
Management of oxaliplatin-induced peripheral neuropathy. Ther Clin Risk Manag (2005) 1.16
Oxaliplatin: a review in the era of molecularly targeted therapy. Curr Oncol (2011) 1.15
Multimodal assessment of painful peripheral neuropathy induced by chronic oxaliplatin-based chemotherapy in mice. Mol Pain (2011) 1.12
Oxaliplatin-induced neuropathy in colorectal cancer. J Oncol (2011) 1.07
Mechanisms involved in the development of chemotherapy-induced neuropathy. Pain Manag (2015) 1.01
N-acetylcysteine has neuroprotective effects against oxaliplatin-based adjuvant chemotherapy in colon cancer patients: preliminary data. Support Care Cancer (2006) 0.99
An animal model of oxaliplatin-induced cold allodynia reveals a crucial role for Nav1.6 in peripheral pain pathways. Pain (2013) 0.98
Involvement of spinal NR2B-containing NMDA receptors in oxaliplatin-induced mechanical allodynia in rats. Mol Pain (2011) 0.98
Dose effects of oxaliplatin on persistent and transient Na+ conductances and the development of neurotoxicity. PLoS One (2011) 0.92
Calcium and magnesium prophylaxis for oxaliplatin-related neurotoxicity: is it a trade-off between drug efficacy and toxicity? Oncologist (2011) 0.92
Treatment of oxaliplatin-induced peripheral neuropathy by intravenous mangafodipir. J Clin Invest (2013) 0.90
Oxaliplatin neurotoxicity--no general ion channel surface-charge effect. J Negat Results Biomed (2009) 0.89
Neurological adverse effects caused by cytotoxic and targeted therapies. Nat Rev Clin Oncol (2009) 0.88
A reversible coma after oxaliplatin administration suggests a pathogenetic role of electrolyte imbalance. Eur J Clin Pharmacol (2008) 0.87
Duloxetine improves oxaliplatin-induced neuropathy in patients with colorectal cancer: an open-label pilot study. Support Care Cancer (2011) 0.87
L type Ca²+ channel blockers prevent oxaliplatin-induced cold hyperalgesia and TRPM8 overexpression in rats. Mol Pain (2012) 0.85
Phase 1 study of an oxaliplatin and etoposide regimen in pediatric patients with recurrent solid tumors. Cancer (2009) 0.85
Oxaliplatin neurotoxicity of sensory transduction in rat proprioceptors. J Neurophysiol (2011) 0.84
Targeting neuroprotection as an alternative approach to preventing and treating neuropathic pain. Neurotherapeutics (2009) 0.82
Cold sensitivity of TRPA1 is unveiled by the prolyl hydroxylation blockade-induced sensitization to ROS. Nat Commun (2016) 0.81
Gender-specific genomic profiling in metastatic colorectal cancer patients treated with 5-fluorouracil and oxaliplatin. Pharmacogenomics (2011) 0.81
Oral Calcium Ameliorating Oxaliplatin-Induced Peripheral Neuropathy. J Appl Res (2004) 0.81
Nervous System of Periplaneta americana Cockroach as a Model in Toxinological Studies: A Short Historical and Actual View. J Toxicol (2012) 0.80
Role of a novel maintained low-voltage-activated inward current permeable to sodium and calcium in pacemaking of insect neurosecretory neurons. Invert Neurosci (2005) 0.80
Preparation and In Vivo Evaluation of Dichloro(1,2-Diaminocyclohexane)platinum(II)-Loaded Core Cross-Linked Polymer Micelles. Chemother Res Pract (2012) 0.79
MC11C4: a pilot randomized, placebo-controlled, double-blind study of venlafaxine to prevent oxaliplatin-induced neuropathy. Support Care Cancer (2015) 0.79
Predictors of duloxetine response in patients with oxaliplatin-induced painful chemotherapy-induced peripheral neuropathy (CIPN): a secondary analysis of randomised controlled trial - CALGB/alliance 170601. Eur J Cancer Care (Engl) (2015) 0.78
New Insights into Potential Prevention and Management Options for Chemotherapy-Induced Peripheral Neuropathy. Asia Pac J Oncol Nurs (2016) 0.78
Long-term administration and efficacy of oxaliplatin with no neurotoxicity in a patient with rectal cancer: Association between neurotoxicity and the GSTP1 polymorphism. Oncol Lett (2014) 0.78
Effects of calcium and magnesium on acute and chronic neurotoxicity caused by oxaliplatin: A meta-analysis. Exp Ther Med (2012) 0.78
Review of Cisplatin and oxaliplatin in current immunogenic and monoclonal antibody treatments. Oncol Rev (2014) 0.78
Oxaliplatin-induced neurotoxicity involves TRPM8 in the mechanism of acute hypersensitivity to cold sensation. Brain Behav (2012) 0.78
Chemotherapy-induced peripheral neuropathy: an update on the current understanding. F1000Res (2016) 0.78
Transient bilateral abducens neuropathy with post-tetanic facilitation and acute hypokalemia associated with oxaliplatin: a case report. J Med Case Rep (2010) 0.77
[Painful hyperexcitability syndrome with oxaliplatin containing chemotherapy. Clinical features, pathophysiology and therapeutic options]. Schmerz (2008) 0.77
A novel path to chronic proprioceptive disability with oxaliplatin: Distortion of sensory encoding. Neurobiol Dis (2016) 0.76
Oxaliplatin: pre-clinical perspectives on the mechanisms of action, response and resistance. Ecancermedicalscience (2009) 0.76
Predicting effects on oxaliplatin clearance: in vitro, kinetic and clinical studies of calcium- and magnesium-mediated oxaliplatin degradation. Sci Rep (2017) 0.75
Assessment of antitumor activity and acute peripheral neuropathy of 1,2-diaminocyclohexane platinum (II)-incorporating micelles (NC-4016). Int J Nanomedicine (2014) 0.75
Oncologic Outcomes of Stage IIIA Colon Cancer for Different Chemotherapeutic Regimens. J Korean Soc Coloproctol (2012) 0.75
AGXT and ERCC2 polymorphisms are associated with clinical outcome in metastatic colorectal cancer patients treated with 5-FU/oxaliplatin. Pharmacogenomics J (2015) 0.75
Eastern Canadian colorectal cancer consensus conference: application of new modalities of staging and treatment of gastrointestinal cancers. Curr Oncol (2012) 0.75
Analysis of neurosensory adverse events induced by FOLFOX4 treatment in colorectal cancer patients: a comparison between two Asian studies and four Western studies. Cancer Med (2012) 0.75
Evaluation of Cisplatin Neurotoxicity in Cultured Rat Dorsal Root Ganglia via Cytosolic Calcium Accumulation. Balkan Med J (2016) 0.75
Efficacy of Drug Interventions for Chemotherapy-Induced Chronic Peripheral Neurotoxicity: A Network Meta-analysis. Front Neurol (2017) 0.75
Case 12: my doctor says that I have ALS! MedGenMed (2006) 0.75
Phase II study of oxaliplatin, fluorouracil, and folinic acid in locally advanced or metastatic gastric cancer patients. J Clin Oncol (2002) 2.15
Proceedings: Selective inhibition of potassium current in the giant axon of the cockroach. J Physiol (1974) 2.03
A phase III randomised trial of LV5FU2 + irinotecan versus LV5FU2 alone in adjuvant high-risk colon cancer (FNCLCC Accord02/FFCD9802). Ann Oncol (2009) 1.92
Clinical pharmacokinetics of oxaliplatin: a critical review. Clin Cancer Res (2000) 1.81
Two consecutive phase II studies of oxaliplatin (L-OHP) for treatment of patients with advanced colorectal carcinoma who were resistant to previous treatment with fluoropyrimidines. Ann Oncol (1996) 1.76
Ductal carcinoma in situ of the male breast. Analysis of 31 cases. Eur J Cancer (1997) 1.67
Local and sustained delivery of 5-fluorouracil from biodegradable microspheres for the radiosensitization of glioblastoma: a pilot study. Cancer (1999) 1.60
[Effects of 4-amino-pyridine on the nervous system of insects: the cockroach (Periplaneta americana L.)]. C R Seances Soc Biol Fil (1972) 1.57
[Paraneoplastic syndromes (1)]. Bull Cancer (1993) 1.39
Gemcitabine combined with oxaliplatin in advanced pancreatic adenocarcinoma: final results of a GERCOR multicenter phase II study. J Clin Oncol (2002) 1.39
5-Fluorouracil-related severe toxicity: a comparison of different methods for the pretherapeutic detection of dihydropyrimidine dehydrogenase deficiency. Cancer Lett (2006) 1.25
Pharmacokinetic and pharmacogenetic determinants of the activity and toxicity of irinotecan in metastatic colorectal cancer patients. Br J Cancer (2008) 1.13
Dose monitoring of 5-fluorouracil in patients with colorectal or head and neck cancer--status of the art. Crit Rev Oncol Hematol (1999) 1.09
Long-term weekly treatment of colorectal metastatic cancer with fluorouracil and leucovorin: results of a multicentric prospective trial of fluorouracil dosage optimization by pharmacokinetic monitoring in 152 patients. J Clin Oncol (1998) 1.05
Scorpion toxins affecting sodium current inactivation bind to distinct homologous receptor sites on rat brain and insect sodium channels. J Biol Chem (1996) 1.04
The influence of fluorouracil outcome parameters on tolerance and efficacy in patients with advanced colorectal cancer. Pharmacogenomics J (2007) 0.99
Dose and time dependencies of 5-fluorouracil pharmacokinetics. Clin Pharmacol Ther (2000) 0.98
Docetaxel in combination with 5-fluorouracil in patients with metastatic breast cancer previously treated with anthracycline-based chemotherapy: a phase I, dose-finding study. Eur J Cancer (2000) 0.96
Complex intracellular messenger pathways regulate one type of neuronal alpha-bungarotoxin-resistant nicotinic acetylcholine receptors expressed in insect neurosecretory cells (dorsal unpaired median neurons). Mol Pharmacol (2001) 0.96
Pre- and postsynaptic effects of taurine and GABA in the cockroach central nervous system. Can J Neurol Sci (1979) 0.95
Dorsal unpaired median neurones in the insect central nervous system: towards a better understanding of the ionic mechanisms underlying spontaneous electrical activity. J Exp Biol (2000) 0.95
Phase II study of oxaliplatin and fluorouracil in taxane- and anthracycline-pretreated breast cancer patients. J Clin Oncol (2002) 0.95
The putative bioactive surface of insect-selective scorpion excitatory neurotoxins. J Biol Chem (1999) 0.94
Isolation, synthesis and pharmacological characterization of delta-palutoxins IT, novel insecticidal toxins from the spider Paracoelotes luctuosus (Amaurobiidae). Eur J Biochem (2000) 0.93
Functional expression and genetic alteration of an alpha scorpion neurotoxin. Biochemistry (1996) 0.93
Phase I and pharmacokinetic study of the multitargeted antifolate pemetrexed in combination with oxaliplatin in patients with advanced solid tumors. Ann Oncol (2004) 0.92
Peptides of arachnid venoms with insecticidal activity targeting sodium channels. Comp Biochem Physiol C Toxicol Pharmacol (2006) 0.91
Two distinct low-voltage-activated Ca2+ currents contribute to the pacemaker mechanism in cockroach dorsal unpaired median neurons. J Neurophysiol (1996) 0.90
Alpha-scorpion toxins binding on rat brain and insect sodium channels reveal divergent allosteric modulations by brevetoxin and veratridine. J Biol Chem (1995) 0.90
In vitro folding and functional analysis of an anti-insect selective scorpion depressant neurotoxin produced in Escherichia coli. Protein Expr Purif (1997) 0.90
A scorpion venom neurotoxin paralytic to insects that affects sodium current inactivation: purification, primary structure, and mode of action. Biochemistry (1990) 0.89
Biophysical properties of scorpion alpha-toxin-sensitive background sodium channel contributing to the pacemaker activity in insect neurosecretory cells (DUM neurons). Eur J Neurosci (1999) 0.88
A recombinant insect-specific alpha-toxin of Buthus occitanus tunetanus scorpion confers protection against homologous mammal toxins. Eur J Biochem (1996) 0.87
Electrophysiological analysis of the neurotoxic action of a funnel-web spider toxin, delta-atracotoxin-HV1a, on insect voltage-gated Na+ channels. J Exp Biol (2001) 0.87
NMR structures and activity of a novel alpha-like toxin from the scorpion Leiurus quinquestriatus hebraeus. J Mol Biol (1999) 0.87
[Acute cardiac toxicity of 5-fluorouracil: pharmacokinetic correlation]. Bull Cancer (1991) 0.87
Scorpion alpha-like toxins, toxic to both mammals and insects, differentially interact with receptor site 3 on voltage-gated sodium channels in mammals and insects. Eur J Neurosci (1999) 0.86
Multicenter phase II-III study of oxaliplatin plus cyclophosphamide vs. cisplatin plus cyclophosphamide in chemonaive advanced ovarian cancer patients. Ann Oncol (2001) 0.86
Cumulative pharmacokinetic study of oxaliplatin, administered every three weeks, combined with 5-fluorouracil in colorectal cancer patients. Clin Cancer Res (1997) 0.86
Early events of the inflammatory reaction induced in rat brain by lipopolysaccharide intracerebral injection: relative contribution of peripheral monocytes and activated microglia. Brain Res (1996) 0.86
Effect of stereotactic implantation of biodegradable 5-fluorouracil-loaded microspheres in healthy and C6 glioma-bearing rats. Neurosurgery (1996) 0.85
Chronopharmacokinetics of oral tegafur and uracil in colorectal cancer patients. Clin Pharmacol Ther (2007) 0.85
Insect toxic component from the venom of a chactoid scorpion, Scorpio maurus palmatus (Scorpionidae). J Biol Chem (1982) 0.85
Effects of a centipede venom fraction on insect nervous system, a native Xenopus oocyte receptor and on an expressed Drosophila muscarinic receptor. Toxicon (1999) 0.85
[Bone metastases of colorectal cancers: apropos of 8 cases]. Rev Med Interne (1993) 0.84
The toxin Tx4(6-1) from the spider Phoneutria nigriventer slows down Na(+) current inactivation in insect CNS via binding to receptor site 3. J Insect Physiol (2002) 0.84
Phase II multicentre study of docetaxel plus 5-fluorouracil in patients with anthracycline-pretreated metastatic breast cancer. Br J Cancer (2003) 0.84
Predicting the efficacy of first iodine-131 treatment in differentiated thyroid carcinoma. J Nucl Med (1997) 0.84
Multicenter non-randomized phase II study of raltitrexed (Tomudex) and oxaliplatin in non-pretreated metastatic colorectal cancer patients. Ann Oncol (2002) 0.83
Early biotransformations of oxaliplatin after its intravenous administration to cancer patients. Drug Metab Dispos (2000) 0.83
Inflammatory breast metastasis from primary ovarian cancer: case report. Eur J Gynaecol Oncol (1999) 0.83
Sodium channel modifiers from scorpion venom: structure-activity relationship, mode of action and application. Toxicon (1998) 0.83
Cockroach giant interneurones stained by cobalt-backfilling of dissected axons. J Exp Biol (1980) 0.82
Separation and identification of multiple potassium currents regulating the pacemaker activity of insect neurosecretory cells (DUM neurons). J Neurophysiol (1995) 0.82
Actions of insect toxin and other toxins derived from the venom of the scorpion Androctonus australis on isolated giant axons of the cockroach (Periplaneta americana). J Exp Biol (1982) 0.82
Co-existence in DUM neurones of two GluCl channels that differ in their picrotoxin sensitivity. Neuroreport (2000) 0.82
An excitatory and a depressant insect toxin from scorpion venom both affect sodium conductance and possess a common binding site. Arch Biochem Biophys (1985) 0.81
[Pharmacokinetic properties of platinium derivatives]. Bull Cancer (2001) 0.81
Alpha-bungarotoxin blocks excitatory post-synaptic potentials in an identified insect interneurone [proceedings]. J Physiol (1979) 0.80
Refined electrophysiological analysis suggests that a depressant toxin is a sodium channel opener rather than a blocker. Life Sci (1997) 0.80
Na+-Dependent neuritic spikes initiate Ca2+-dependent somatic plateau action potentials in insect dorsal paired median neurons. J Neurophysiol (1998) 0.80
Sensitive MS/MS-liquid chromatography assay for simultaneous determination of tegafur, 5-fluorouracil and 5-fluorodihydrouracil in plasma. J Chromatogr B Analyt Technol Biomed Life Sci (2005) 0.80
[Pharmacology of platinum analogs-taxanes interactions]. Bull Cancer (2000) 0.79
Expression of the multidrug resistance-associated protein gene in refractory lymphoma: quantitation by a validated polymerase chain reaction assay. Blood (1997) 0.79
Changes in Na channel properties of frog and rat skeletal muscles induced by the AaH II toxin from the scorpion Androctonus australis. Pflugers Arch (1989) 0.79
Threonine6-bradykinin in the venom of the wasp Colpa interrupta (F.) presynaptically blocks nicotinic synaptic transmission in the insect CNS. Comp Biochem Physiol C (1990) 0.79
[Cancers of unknown origin: 311 cases]. Bull Cancer (2001) 0.79
A phase I-II, dose-escalating trial of ZD9331 in combination with irinotecan (CPT11) in previously pretreated metastatic colorectal cancer patients. Bull Cancer (2004) 0.79
Rapid and sensitive high-performance liquid chromatographic analysis of halogenopyrimidines in plasma. J Chromatogr B Biomed Sci Appl (1997) 0.79
Purification, structure and activity of three insect toxins from Buthus occitanus tunetanus venom. Toxicon (1997) 0.79
A new scorpion venom toxin paralytic to insects that affects Na+ channel activation. Purification, structure, antigenicity and mode of action. Eur J Biochem (1996) 0.79
Benefits of pharmacological knowledge in the design and monitoring of cancer chemotherapy. Pathol Oncol Res (1998) 0.79
Hyperpolarization-activated inward potassium and calcium-sensitive chloride currents in beating pacemaker insect neurosecretory cells (dorsal unpaired median neurons). Neuroscience (1999) 0.79
[Modifications by 4 amino-pyridine of electric characteristics of the isolated giant axon of an insect, the cockroach (Periplaneta americana L.)]. C R Seances Soc Biol Fil (1974) 0.78
Transient Na(+)-activated K+ current in beating pacemaker-isolated adult insect neurosecretory cells (dum neurones). Neurosci Lett (1994) 0.78
Pharmacological properties of axonal sodium channels in the cockroach Periplaneta americana L. II. Slowing of sodium current turn-off by Condylactis toxin. J Exp Biol (1979) 0.78
Multicenter evaluation of a novel nanoparticle immunoassay for 5-fluorouracil on the Olympus AU400 analyzer. Ther Drug Monit (2009) 0.78
Poneratoxin, a new toxin from an ant venom, reveals an interconversion between two gating modes of the Na channels in frog skeletal muscle fibres. Pflugers Arch (1992) 0.78
Nicotine increases [Ca2+]i and regulates electrical activity in insect neurosecretory cells (DUM neurons) via an acetylcholine receptor with 'mixed' nicotinic-muscarinic pharmacology. Neurosci Lett (1996) 0.78
Photoaffinity labeling of scorpion toxin receptors associated with insect synaptosomal Na+ channels. Biochem Biophys Res Commun (1988) 0.77
Synaptic transmission in the sixth ganglion of the cockroach: action of 4-aminopyridine. J Exp Biol (1976) 0.77
Poneratoxin, a novel peptide neurotoxin from the venom of the ant, Paraponera clavata. Comp Biochem Physiol C (1991) 0.77
Block of synaptic transmission in insect CNS by toxins from the venom of the wasp Megascolia flavifrons (Fab.). Comp Biochem Physiol C (1987) 0.77
[Treatment of acute chemically induced diarrhea by inhibition of enkephalinase. Results of a pilot study]. Gastroenterol Clin Biol (1995) 0.77
Effects of several sea anemone and scorpion toxins on excitability and ionic currents in the giant axon of the cockroach. J Physiol (Paris) (1984) 0.77
Anatomy and targets of Dorsal Unpaired Median neurones in the Terminal Abdominal Ganglion of the male cockroach Periplaneta americana L. J Comp Neurol (1996) 0.77